Short-term changes of angiogenesis factors after transarterial radioembolization in hepatocellular carcinoma patients

Short-term changes of angiogenesis factors after transarterial radioembolization in hepatocellular carcinoma patients

PURPOSETo analyze changes in angiogenesis factors after transarterial radioembolization (TARE) with Yttrium- 90-loaded resin microspheres in hepatocellular carcinoma (HCC) patients.METHODSInterleukin-6, interleukin-8, hepatocyte growth factor, platelet-derived growth factor, fibroblast growth factor...

Full description

Bibliographic Details
Main Authors:	Hüseyin Tuğsan Ballı, Kairgeldy Aikimbaev, İsa Güney Burak, Ferhat Can Pişkin
Format:	Article
Language:	English
Published:	Galenos Publishing House 2023-09-01
Series:	Diagnostic and Interventional Radiology
Subjects:	angiogenesis hepatocellular carcinoma resin microspheres transarterial radioembolization y-90
Online Access:	http://www.dirjournal.org/archives/archive-detail/article-preview/short-term-changes-of-angiogenesis-factors-after-t/57976

Similar Items

The Influence of Additional Treatments on the Survival of Patients Undergoing Transarterial Radioembolization (TARE)
by: Natale Quartuccio, et al.
Published: (2024-03-01)

Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yi Yang, et al.
Published: (2018-09-01)

Transarterial radioembolization for hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2016-07-01)

Radioembolization for the treatment of hepatocellular carcinoma
by: Hyo-Cheol Kim
Published: (2017-06-01)

Radioembolization for hepatocellular carcinoma: what clinicians need to know
by: Jin Woo Choi, et al.
Published: (2022-03-01)

Radioembolization Treatment for Liver Cancer
by: Ezgi Başak ERDOĞAN, et al.
Published: (2016-04-01)

Superselective transarterial radioembolization for the treatment of hepatocellular carcinoma
by: Gyoung Min Kim
Published: (2021-10-01)

Low Dose Rate Radiosensitization of Hepatocellular Carcinoma In Vitro and in Patients
by: Kyle C. Cuneo, et al.
Published: (2014-08-01)

Analysis of Periprocedural X-ray Exposure in Transarterial Radioembolization with Glass or Resin Microspheres
by: Constantin Ehrengut, et al.
Published: (2023-12-01)

Dynamic Lymphocyte Changes Following Transarterial Radioembolization: Association with Normal Liver Dose and Effect on Overall Survival
by: Young S, et al.
Published: (2022-02-01)

Inter-observer variability of 90Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
by: Nicolas Meyers, et al.
Published: (2020-05-01)

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
by: Tamás Benkö, et al.
Published: (2022-05-01)

Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis
by: Victor Lopez-Lopez, et al.
Published: (2023-04-01)

Radiometal-Labeled Chitosan Microspheres as Transarterial Radioembolization Agents against Hepatocellular Carcinoma
by: Hui-Wen Chan, et al.
Published: (2022-03-01)

Outcome of transarterial radioembolization in patients with hepatocellular carcinoma as a first-line interventional therapy and after a previous transarterial chemoembolization
by: Julia Wagenpfeil, et al.
Published: (2024-02-01)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
by: Moon Haeng Hur, et al.
Published: (2023-07-01)

Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
by: Sung Won Chung, et al.
Published: (2023-02-01)

Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model
by: E. Courtney Henry, et al.
Published: (2022-03-01)

Transarterial Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma Patients: Outcome Assessment Applying a Prognostic Score
by: Imke Schatka, et al.
Published: (2022-10-01)

Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility
by: Qian Yu, et al.
Published: (2023-11-01)

Extrahepatic transarterial radioembolization to treat fibrolamellar hepatocellular carcinoma: A case report
by: Damir Ljuboja, MD, MBA, et al.
Published: (2020-12-01)

Transarterial radioembolization with Iodine-131-Lipiodol for hepatic metastases from gastrointestinal malignancies – Experience in tertiary care oncology center in India
by: Vidya Bhargavi, et al.
Published: (2019-01-01)

Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer
by: Rou Li, et al.
Published: (2021-01-01)

Transarterial Radioembolization (TARE) with 131Iodine-Lipiodol for Unresectable Primary Hepatocellular Carcinoma: Experience from a Tertiary Care Center in India
by: Aakash Patel, et al.
Published: (2021-04-01)

Transarterial therapy: An evolving treatment modality of hepatocellular carcinoma
by: Khalid A Jazieh, et al.
Published: (2014-01-01)

Transarterial radioembolization: a systematic review on gaining control over the parameters that influence microsphere distribution
by: T. J. Snoeijink, et al.
Published: (2023-12-01)

Preparation and In Vitro Evaluation of Neutron-Activated, Theranostic Samarium-153-Labeled Microspheres for Transarterial Radioembolization of Hepatocellular Carcinoma and Liver Metastasis
by: Yin How Wong, et al.
Published: (2019-11-01)

How the Rigid and Deformable Image Registration Approaches Affect the Absorbed Dose Estimation Using Images Collected before and after Transarterial Radioembolization with <sup>90</sup>Y Resin Microspheres in a Clinical Setting
by: Giuseppe Della Gala, et al.
Published: (2022-12-01)

Rapid predictive dosimetry for radioembolization
by: Yung Hsiang Kao
Published: (2024-01-01)

A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study
by: Armeen Mahvash, et al.
Published: (2022-03-01)

Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects
by: Philippe d’Abadie, et al.
Published: (2021-06-01)

Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series
by: Sim Vermeulen, et al.
Published: (2023-09-01)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
by: Raval eMihir, et al.
Published: (2014-07-01)

Beyond hepatocellular carcinoma and colorectal metastasis: The expanding applications of radioembolization
by: Omar eZurkiya, et al.
Published: (2014-06-01)

İntrahepatik kolanjiyosellüler karsinomlarda transarteriyel radyoembolizasyon tedavisinin sağkalım üzerine etkisi
by: Hüseyin Tuğsan Ballı, et al.
Published: (2019-12-01)

Liver Radioembolization: a New Chapter in Russian Oncology
by: A. D. Kaprin, et al.
Published: (2019-12-01)

Predictive SIRT dosimetry based on a territorial model
by: Nadine Spahr, et al.
Published: (2017-10-01)

Super-selective transarterial chemoembolization of hepatocellular carcinoma with doxorubicin-eluting beads sized 40–75 microns: assessment of efficacy and safety
by: Hüseyin Tuğsan Ballı, et al.
Published: (2020-09-01)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
by: Yu CY, et al.
Published: (2023-01-01)

Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer
by: Robert Drescher, et al.
Published: (2023-06-01)